Evidence map›Paper›PMID 37144488›Full record

ArticleMolecular medicine reports2023

Effect of the combination of

Ozgur Celebi, Ali Taghizadehghalehjoughi, Demet Celebi, Robin Mesnage, Kirill Sergeevich Golokhvast, Andreea Letitia Arsene, Demetrios A Spandidos, Aristidis Tsatsakis

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Ozgur CelebiDepartment of Medical Microbiology, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey.
Ali TaghizadehghalehjoughiDepartment of Medical Pharmacology, Faculty of Medicine, Seyh Edebali University, 11000 Bilecik, Turkey.
Demet CelebiDepartment of Microbiology, Faculty of Veterinary Medicine, Ataturk University, 25240 Erzurum, Turkey.
Robin MesnageDepartment of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, United Kingdom.
Kirill Sergeevich GolokhvastRussian Academy of Education, Moscow, 119121, Russia.
Andreea Letitia ArseneDepartment of General and Pharmaceutical Microbiology, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Demetrios A SpandidosLaboratory of Clinical Virology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece.
Aristidis TsatsakisDepartment of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece.
Atatürk University · TRUniversity of Crete · GRBilecik Şeyh Edebali Üniversitesi · TRCarol Davila University of Medicine and Pharmacy · ROKing's College London · GBRussian Academy of Education · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota plays a key role in maintaining health and regulating the host's immune response. The use of probiotics and concomitant vitamins can increase mucus secretion by improving the intestinal microbial population and prevent the breakdown of tight junction proteins by reducing lipopolysaccharide concentration. Changes in the intestinal microbiome mass affect multiple metabolic and physiological functions. Studies on how this microbiome mass and the regulation in the gastrointestinal tract are affected by probiotic supplements and vitamin combinations have attracted attention. The current study evaluated vitamins K and E and probiotic combinations effects on

Indexed as

ProbioticsStaphylococcal InfectionsEscherichia coliHumansLactobacillus acidophilusStaphylococcus aureusVitamin EVitamin KVitamin K 3VitaminsVitamin EVitamin KVitamin K 3Vitaminsantioxidant activityEscherichia coligut microbiotamethicillin‑resistant Staphylococcus aureusprobioticvitamins

Identifiers

PMID37144488
PMCPMC10196883
OpenAlexW4368364628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.